Trademark: 97403266
Word
GENERXN RESEARCH
Status
Pending
Status Code
651
Status Date
Thursday, December 28, 2023
Serial Number
97403266
Mark Type
3000
Filing Date
Tuesday, May 10, 2022

Trademark Owner History

Classifications
41 Training clinical trial site personnel in the field of drug protocol requirements and the use of tests and rating systems for such protocol
18 Promotional items, namely, all-purpose carrying bags
16 Promotional items, namely, pens
35 Business management assistance and consultation for clinical trials of investigational drugs, namely, arranging for sites to perform clinical trials, arranging for the import, packaging, shipping, labeling, and distribution of drugs and measuring apparatus, placebo drugs, manuals, precursor and analytical chemicals to and from the clinical trial sites, arranging for the central collection of laboratory specimens from the clinical trial sites, preparing statistical reports resulting from the clinical trials
44 Clinical diagnostic services, namely, diagnosis of conditions, diseases or illnesses; performing clinical diagnostic services, namely, diagnosis of predisposition for conditions, diseases or illnesses, characterizations of disease, response to therapy, patient selection, prognosis and reoccurrence; medical and healthcare services
21 Promotional items, namely, cups and mugs
42 Pharmaceutical product evaluation services; scientific research in the nature of conducting clinical trials for others, namely, the preparation, establishment, running, management and processing of clinical trials and clinical trial data; preclinical services, namely, investigation of biological and chemical material for medical purposes; testing of pharmaceuticals, namely, diagnostic, analytical, testing and monitoring services; clinical research in the field of neuroscience; scientific research, namely, conducting and analyzing clinical trials in the field of biotechnology, pharmacology, and medical research; medical research in the field of the design and conducting of clinical trials; technical consulting services in the field of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
The mark consists of the term GENERXN RESEARCH with the depiction of the design of a helix after the letter E in the word GENE and before the letters RXN.
Color is not claimed as a feature of the mark.
"GENE AND RESEARCH FOR CLASSES 35, 41, 42 AND 44 ONLY"

Trademark Events
Mar 27, 2024
Teas Response To Suspension Inquiry Received
Dec 28, 2023
Notification Of Inquiry As To Suspension E-Mailed
Dec 28, 2023
Inquiry To Suspension E-Mailed
Dec 28, 2023
Suspension Inquiry Written
Jun 26, 2023
Notification Of Letter Of Suspension E-Mailed
Jun 26, 2023
Letter Of Suspension E-Mailed
Jun 26, 2023
Suspension Letter Written
Jun 5, 2023
Teas/Email Correspondence Entered
Jun 5, 2023
Correspondence Received In Law Office
Jun 5, 2023
Teas Response To Office Action Received
Mar 4, 2023
Notification Of Non-Final Action E-Mailed
Mar 4, 2023
Non-Final Action E-Mailed
Mar 4, 2023
Non-Final Action Written
Feb 27, 2023
Assigned To Examiner
May 17, 2022
Notice Of Design Search Code E-Mailed
May 16, 2022
New Application Office Supplied Data Entered
May 13, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24